Prostate cancer study using drain fluid test after surgery
Part of Cancer, Kidney & urinary clinical trials.
This study looks at a simple test on the fluid from your drain after prostate surgery to see if it can help predict how your cancer will progress. If you qualify, your participation may help doctors better monitor patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a prostate cancer patient.
- You must have had surgery to remove your prostate (called a radical prostatectomy).
- You must not have had hormone or chemotherapy before your surgery.
- You must not have a urine leak after surgery (this would be checked with a test on the fluid from your drain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a marker (tumor DNA) in your drainage fluid changes after prostate removal surgery. It may help predict the outcome of your cancer, giving you more information about your recovery.
This study looks at how PSA levels in drainage fluid change after prostate removal surgery to predict outcomes. It may help doctors understand your recovery and future risk.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.
This study is looking at blood samples from people with prostate cancer to better understand the disease. It may help researchers find new ways to monitor or treat prostate cancer.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.